Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2022) |  Total Docs. (3years) |
Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 400 | Cancer Innovation | journal | 4 | 20 | 0 | 1148 | 0 | 0 | 0.00 | 57.40 | 43.75 |  | |
| 399 | Current Colorectal Cancer Reports | journal | 0.272 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
| 398 | Onkologe | journal | 0.129 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |  |
| 397 | Clinical Sarcoma Research | journal | 0.131 Q4 | 1 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 |  |
| 396 | European Journal of Oncology | journal | 11 | 3 | 1 | 41 | 1 | 0 | 1.00 | 13.67 | 44.44 |  | |
| 395 | Hepatic Oncology | journal | 3 | 1 | 1 | 24 | 1 | 1 | 1.00 | 24.00 | 0.00 | | |
| 394 | National Toxicology Program technical report series | journal | 0.108 | 22 | 0 | 6 | 0 | 1 | 6 | 0.20 | 0.00 | 0.00 | |
| 393 | Breast Cancer Management | journal | 0.104 Q4 | 2 | 5 | 8 | 167 | 1 | 7 | 0.00 | 33.40 | 73.08 | |
| 392 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 3 | 9 | 369 | 4 | 9 | 0.14 | 123.00 | 55.00 | | |
| 391 | Onkopediatria | journal | 0.103 Q4 | 4 | 0 | 12 | 0 | 1 | 12 | 0.00 | 0.00 | 0.00 |  |
| 390 | European Journal of Cancer, Supplement | journal | 0.571 Q3 | 29 | 0 | 14 | 0 | 29 | 13 | 2.07 | 0.00 | 0.00 | |
| 389 | Cancer Microenvironment | journal | 1.010 Q2 | 51 | 0 | 16 | 0 | 77 | 15 | 0.00 | 0.00 | 0.00 |  |
| 388 | Lung Cancer Management | journal | 0.394 Q3 | 5 | 1 | 16 | 35 | 27 | 14 | 1.69 | 35.00 | 40.00 | |
| 387 | Journal of the National Cancer Center | journal | 2.649 Q1 | 9 | 38 | 19 | 2525 | 179 | 16 | 9.42 | 66.45 | 38.75 |  |
| 386 | Archive of Oncology | journal | 0.117 Q4 | 14 | 6 | 20 | 146 | 5 | 19 | 0.38 | 24.33 | 59.26 |  |
| 385 | European Oncology and Haematology | journal | 0.120 Q4 | 8 | 0 | 24 | 0 | 3 | 22 | 0.29 | 0.00 | 0.00 | |
| 384 | Cancer and Chemotherapy Reviews | journal | 0.119 Q4 | 4 | 10 | 25 | 122 | 3 | 22 | 0.15 | 12.20 | 42.31 |  |
| 383 | European Journal of Oncology Pharmacy | journal | 0.144 Q4 | 6 | 5 | 25 | 120 | 18 | 25 | 0.67 | 24.00 | 40.91 |  |
| 382 | Journal of Skin Cancer | journal | 0.350 Q3 | 15 | 12 | 26 | 517 | 31 | 26 | 1.10 | 43.08 | 50.98 |  |
| 381 | Hematology in Clinical Practice | journal | 1 | 18 | 27 | 677 | 0 | 27 | 0.00 | 37.61 | 57.38 |  | |
| 380 | Journal of Carcinogenesis | journal | 0.570 Q3 | 43 | 5 | 28 | 198 | 124 | 28 | 4.18 | 39.60 | 9.09 |  |
| 379 | Oncology and Therapy | journal | 0.817 Q2 | 8 | 33 | 28 | 1598 | 76 | 25 | 2.81 | 48.42 | 41.41 |  |
| 378 | Gastric and Breast Cancer | journal | 0.101 Q4 | 6 | 6 | 31 | 329 | 0 | 31 | 0.00 | 54.83 | 30.77 |  |
| 377 | International Journal of Breast Cancer | journal | 0.415 Q3 | 23 | 23 | 32 | 972 | 56 | 31 | 1.48 | 42.26 | 49.22 | |
| 376 | International Journal of Surgical Oncology | journal | 0.318 Q3 | 30 | 5 | 32 | 143 | 52 | 32 | 1.70 | 28.60 | 22.50 | |
| 375 | Immuno-Oncology and Technology | journal | 0.691 Q3 | 10 | 8 | 33 | 524 | 67 | 25 | 1.65 | 65.50 | 50.00 | |
| 374 | Journal of Oncological Science | journal | 0.103 Q4 | 2 | 24 | 33 | 609 | 2 | 29 | 0.03 | 25.38 | 31.43 |  |
| 373 | Prostate Cancer | journal | 0.364 Q3 | 15 | 9 | 34 | 449 | 56 | 34 | 1.29 | 49.89 | 43.04 | |
| 372 | Forum of Clinical Oncology | journal | 0.102 Q4 | 6 | 9 | 37 | 269 | 3 | 33 | 0.06 | 29.89 | 52.94 | |
| 371 | Experientia supplementum (2012) | journal | 0.321 | 11 | 26 | 40 | 4052 | 62 | 0 | 1.26 | 155.85 | 0.00 | |
| 370 | Lung Cancer: Targets and Therapy | journal | 0.863 Q2 | 27 | 8 | 41 | 418 | 166 | 41 | 3.72 | 52.25 | 57.14 |  |
| 369 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.800 Q2 | 13 | 17 | 41 | 972 | 137 | 37 | 2.87 | 57.18 | 45.24 | |
| 368 | Annals of Pancreatic Cancer | journal | 0.405 Q3 | 7 | 11 | 45 | 363 | 35 | 41 | 0.48 | 33.00 | 18.18 | |
| 367 | Melanoma Management | journal | 0.699 Q2 | 14 | 3 | 45 | 80 | 90 | 39 | 1.77 | 26.67 | 62.50 | |
| 366 | Current Gynecologic Oncology | journal | 0.103 Q4 | 6 | 0 | 47 | 0 | 4 | 47 | 0.00 | 0.00 | 0.00 | |
| 365 | Iranian Journal of Breast Diseases | journal | 0.110 Q4 | 3 | 36 | 47 | 1277 | 10 | 44 | 0.21 | 35.47 | 50.45 |  |
| 364 | Trends in Immunotherapy | journal | 0.208 Q4 | 4 | 19 | 48 | 546 | 41 | 45 | 0.94 | 28.74 | 47.62 | |
| 363 | Hematologia | journal | 0.103 Q4 | 5 | 0 | 52 | 0 | 2 | 44 | 0.06 | 0.00 | 0.00 | |
| 362 | Revista Venezolana de Oncologia | journal | 6 | 21 | 52 | 370 | 4 | 44 | 0.10 | 17.62 | 39.39 |  | |
| 361 | World Journal of Oncology | journal | 1.294 Q1 | 10 | 47 | 54 | 1559 | 299 | 52 | 5.54 | 33.17 | 44.06 |  |
| 360 | Healthbook TIMES Oncology Hematology | journal | 0.164 Q4 | 3 | 32 | 57 | 972 | 14 | 55 | 0.24 | 30.38 | 46.51 | |
| 359 | Kidney Cancer | journal | 0.406 Q3 | 10 | 23 | 57 | 882 | 60 | 50 | 0.53 | 38.35 | 41.30 | |
| 358 | Journal of the National Cancer Institute. Monographs | journal | 1.541 Q1 | 95 | 23 | 58 | 966 | 293 | 54 | 4.54 | 42.00 | 62.22 | |
| 357 | Libri Oncologici | journal | 0.137 Q4 | 4 | 23 | 58 | 495 | 12 | 58 | 0.18 | 21.52 | 61.00 |  |
| 356 | Cancer Nanotechnology | journal | 0.882 Q2 | 36 | 42 | 59 | 2014 | 380 | 57 | 4.96 | 47.95 | 43.21 | |
| 355 | Revisiones en Cancer | journal | 0.101 Q4 | 2 | 38 | 61 | 1765 | 0 | 61 | 0.00 | 46.45 | 50.00 | |
| 354 | Foregut | journal | 4 | 72 | 64 | 1843 | 13 | 47 | 0.20 | 25.60 | 29.74 | | |
| 353 | Oncology Reviews | journal | 0.861 Q2 | 31 | 9 | 64 | 717 | 235 | 63 | 3.05 | 79.67 | 50.00 | |
| 352 | Drug Resistance Updates | journal | 4.391 Q1 | 132 | 28 | 65 | 5855 | 1577 | 65 | 23.73 | 209.11 | 43.78 | |
| 351 | Sarkomy Kostej, Magkih Tkanej i Opuholi Kozi | journal | 3 | 24 | 65 | 734 | 15 | 59 | 0.19 | 30.58 | 38.30 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data